Theragenics Brachytherapy Portfolio - Data Sheet

An industry pioneer and leader, Theragenics has an unparalleled history of more than 35 years in the manufacture and global supply and distribution of low-dose rate (LDR) brachytherapy seeds for the treatment of prostate cancer, intra-ocular malignancies, and other tumor types with radiosensitivity